Drawing for GASTROPLUS

USPTO serial 87913414

GASTROPLUS

Reviewed by CopyMark Law Group

Reg. 5642244Status 702Registered
Filing date
Status date
Registration date
Jan 1, 2019
Examiner
SONNEBORN, TRICIA L
Law office
Historical data usage

What this means

Status 702 means the registration is active, Section 8 was accepted, and a Section 15 declaration of incontestability was also accepted. Incontestability strengthens your rights by limiting certain challenges after five years of continuous use. Continue use in commerce and plan for the 10-year Section 8 and 9 renewal.

Status 702: Status 702 means the registration is active, Section 8 was accepted, and a Section 15 declaration of incontestability was also accepted. Incontestability strengthens your rights by limiting certain challenges after five years of continuous use.

Need help with GASTROPLUS?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

M. Bud Nelson

42505 10th Street WestLancaster, CA 93534United States

Goods and services

ClassDescriptionStatusFirst use
009Computer software, namely, computer software for modeling and the conducting of simulations of properties of drugs or chemicals including absorption, release rate, bioavailability, pharmacokinetics, and pharmacodynamics; computer software which allows for prediction of drug-to-drug interactions; computer software for the prediction of drug effects on animals and virtual patient populations; computer software which allows researchers to adjust pharmacodynamic models to observed data and to then use the resulting fitted models to predict pharmacodynamic changes due to changes in dose, dosage form, and dosing regimen of a drug or chemical; computer software which allows for the generation of in vitro-in vivo correlations; computer software which allows for the prediction of absorption and systemic distribution/elimination for large moleculesACTIVEAug 31, 1998

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Jul 23, 2024NA85NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED—
Jul 23, 2024C15AREGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.—
Jul 19, 2024APRECASE ASSIGNED TO POST REGISTRATION PARALEGAL—
Jan 5, 2024E815TEAS SECTION 8 & 15 RECEIVED—
Jan 1, 2024REM1COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED—
Jan 1, 2019R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
Oct 16, 2018NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Oct 16, 2018PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Sep 26, 2018NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
Sep 6, 2018CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Aug 31, 2018DOCKASSIGNED TO EXAMINER—
May 17, 2018NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
May 12, 2018NWAPNEW APPLICATION ENTERED—

Frequently asked questions

Related guidance